{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1370286444979005697.json","@type":"Product","dc:title":[{"@value":"Circulating tumor cells (CTCs) in lung cancer: Current status and future perspectives"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380286444979005952","@type":"Researcher","foaf:name":[{"@value":"Tanaka"}]}],"publication":{"prism:publicationName":[{"@value":"Lung Cancer (Auckl)"}],"prism:publicationDate":"2010","prism:volume":"1","prism:startingPage":"77"},"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360848664623527680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3892/ol.2017.7671_references_1o6YUg89j6yCaLaLpD1wIQ8WYPH"}]}